论文信息 - Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in diffuse large B-cell lymphoma (DLBCL) and multiple myeloma (MM) - 字舞流文

Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in diffuse large B-cell lymphoma (DLBCL) and multiple myeloma (MM)

T. Meyer | L. Paz-Ares | P. Munster | L. Wong | Shuichan Xu | T. Witzig | E. Ocio | R. Chopra | M. Mita | H. Arkenau | V. Ribrag | A. Goy | M. Gutierrez | J. Delord | A. Varga | J. Carmichael | A. Mahipal | K. Hege | Xiaoling Wu | A. James